HK1036412A1 - Anit-inflammatory eye drops. - Google Patents

Anit-inflammatory eye drops.

Info

Publication number
HK1036412A1
HK1036412A1 HK01107412A HK01107412A HK1036412A1 HK 1036412 A1 HK1036412 A1 HK 1036412A1 HK 01107412 A HK01107412 A HK 01107412A HK 01107412 A HK01107412 A HK 01107412A HK 1036412 A1 HK1036412 A1 HK 1036412A1
Authority
HK
Hong Kong
Prior art keywords
anit
eye drops
inflammatory eye
inflammatory
drops
Prior art date
Application number
HK01107412A
Other languages
English (en)
Inventor
Kensaku Miyake
Yoshihiro Tsuriya
Hiroko Yageta
Hidekazu Suzuki
Yoshihiro Toyoda
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of HK1036412A1 publication Critical patent/HK1036412A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK01107412A 1998-05-15 2001-10-24 Anit-inflammatory eye drops. HK1036412A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15078898 1998-05-15
JP5817399 1999-03-05
PCT/JP1999/002522 WO1999059634A1 (fr) 1998-05-15 1999-05-14 Gouttes oculaires anti-inflammatoires

Publications (1)

Publication Number Publication Date
HK1036412A1 true HK1036412A1 (en) 2002-01-04

Family

ID=26399243

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107412A HK1036412A1 (en) 1998-05-15 2001-10-24 Anit-inflammatory eye drops.

Country Status (9)

Country Link
US (1) US6495603B1 (ko)
EP (1) EP1082966A4 (ko)
JP (1) JP4234907B2 (ko)
KR (1) KR100627620B1 (ko)
CN (1) CN1175904C (ko)
AU (1) AU754064B2 (ko)
CA (1) CA2332271C (ko)
HK (1) HK1036412A1 (ko)
WO (1) WO1999059634A1 (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037838A1 (fr) 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse ophtalmique
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
MXPA01013257A (es) * 2001-12-18 2003-06-25 Arturo Jimenez Bayardo Suspension oftalmica de rofecoxib para el tratamiento de la inflamacion y el dolor ocular.
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
BR0318395A (pt) * 2003-07-10 2006-08-01 Arturo Jimenez Bayardo método para preparar uma solução aquosa de meloxicam e a solução aquosa resultante
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
MX2007000208A (es) 2004-07-01 2007-08-07 Schepens Eye Res Inst Composiciones y metodos para tratar trastornos y condiciones del ojo.
DK1824493T3 (da) * 2004-12-06 2008-12-08 Janssen Pharmaceutica Nv Oral suspension, der omfatter meloxicam
US20080145430A1 (en) * 2004-12-08 2008-06-19 Santipharp Panmai Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective Inhibitor
JP4922588B2 (ja) * 2005-09-13 2012-04-25 参天製薬株式会社 角結膜障害治療剤
KR20080059269A (ko) * 2005-09-30 2008-06-26 베링거잉겔하임베트메디카게엠베하 멜록시캄을 함유하는 약제학적 제제
JP5098156B2 (ja) * 2005-11-16 2012-12-12 大正製薬株式会社 水分分泌促進剤
JP2011502990A (ja) * 2007-11-05 2011-01-27 ボーシュ アンド ローム インコーポレイティド 薬物送達用ビヒクルとしての水非混和性物質
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN102908307A (zh) * 2011-08-03 2013-02-06 天津市嵩锐医药科技有限公司 供注射用盐酸决奈达隆药物组合物及其制备方法
AU2012311239B2 (en) 2011-09-20 2017-10-19 Allergan, Inc. Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
CN103110575B (zh) * 2013-03-07 2014-11-05 宁夏康亚药业有限公司 一种美洛昔康滴眼液及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
FR2679135B1 (fr) * 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
CA2131992A1 (en) * 1992-03-13 1993-09-16 James W. Young Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
AU1249395A (en) * 1994-01-11 1995-08-01 Ciba-Geigy Ag Topical treatment of ocular photophobia
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
ZA987800B (en) * 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment

Also Published As

Publication number Publication date
CA2332271A1 (en) 1999-11-25
KR100627620B1 (ko) 2006-09-25
US6495603B1 (en) 2002-12-17
KR20010025026A (ko) 2001-03-26
CN1175904C (zh) 2004-11-17
JP4234907B2 (ja) 2009-03-04
EP1082966A1 (en) 2001-03-14
AU3730999A (en) 1999-12-06
CA2332271C (en) 2008-08-05
EP1082966A4 (en) 2004-07-21
WO1999059634A1 (fr) 1999-11-25
CN1301177A (zh) 2001-06-27
AU754064B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
HK1036412A1 (en) Anit-inflammatory eye drops.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
GB9813041D0 (en) Eye tracking technique
HK1016976A1 (en) Resorcinyl-triazine.
AU138171S (en) Goggles
ZA991272B (en) Novel thiobenzamides.
MXPA00012526A (es) Columna mejorada.
ZA981926B (en) Detergent--package combination.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA99733B (en) Ophthalmic composition.
HK1026584A1 (en) Buckle.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
HK1017834A1 (en) Bodyshaper.
HK1021879A1 (en) Carrying case.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA992493B (en) Multiple zone member.
ZA984592B (en) Herbicidal 3,5-difluoropyridines.
HK1028588A1 (en) Case.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA993631B (en) Projectile.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090514